PLC Diagnostics Inc. (PLCD) is developing a novel, rapid diagnostic testing platform for sensitive, robust, inexpensive and simple detection of molecular biomarkers. This new platform is based on the company’s novel microarray chip technology that replaces expensive laser scanning with an intersecting grid of 100 mm-wide waveguides embedded in the chip’s substrate. This technology enables real-time quantification of molecular complex formation on the microarray surface without reagent addition or wash steps, thereby significantly reducing assay complexity and cost so that the platform can be used in point-of-care (POC) settings. 

For more details please see our latest publication in Analytical Chemistry

Our platform offers:

• Diagnostics using 5 minutes assay
• Immunoassays and nucleic acids
• Multiplexing (100 different assays)
• Detection in complex matrices – Serum, whole Blood, Urine etc.
• Exquisite sensitivity – down to 1fM
• Low cost – suitable for Point of Care
• Robustness, compactness and ease of operation

Target Applications

• Acute Myocardial Infarction (AMI) Diagnosis
  
• Traumatic Brain Injury (TBI) Diagnosis
  
• Infectious Diseases
• Targeted DNA Re-Sequencing
• Rapid Gene-Expression panels
• Pathogens & Toxins screening
  

Partnering & Collaboration